SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Isomorphic Labs Receives Option to Co-Fund Development for Higher Royalties

Merck and Isomorphic Labs announced an option for Isomorphic to co-fund development in exchange for elevated royalties.

MRK

Related stories